Ims Health Holdings Stock Revenue
IMS Health Holdings fundamentals help investors to digest information that contributes to IMS Health's financial success or failures. It also enables traders to predict the movement of IMS Stock. The fundamental analysis module provides a way to measure IMS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IMS Health stock.
IMS |
IMS Health Holdings Company Revenue Analysis
IMS Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current IMS Health Revenue | 2.92 B |
Most of IMS Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IMS Health Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, IMS Health Holdings reported 2.92 B of revenue. This is 29.72% higher than that of the sector and 35.14% lower than that of the Revenue industry. The revenue for all United States stocks is 69.04% higher than that of the company.
IMS Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IMS Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IMS Health could also be used in its relative valuation, which is a method of valuing IMS Health by comparing valuation metrics of similar companies.IMS Health is currently under evaluation in revenue category among related companies.
IMS Fundamentals
Return On Equity | 0.26 | |||
Return On Asset | 0.0554 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 17.32 % | |||
Current Valuation | 12.23 B | |||
Shares Outstanding | 331 M | |||
Shares Owned By Insiders | 7.00 % | |||
Shares Owned By Institutions | 94.00 % | |||
Number Of Shares Shorted | 6.83 M | |||
Price To Earning | 71.84 X | |||
Price To Book | 5.62 X | |||
Price To Sales | 3.15 X | |||
Revenue | 2.92 B | |||
Gross Profit | 1.5 B | |||
EBITDA | 288.97 M | |||
Net Income | 417 M | |||
Cash And Equivalents | 396 M | |||
Cash Per Share | 1.39 X | |||
Total Debt | 4.2 B | |||
Debt To Equity | 2.58 % | |||
Current Ratio | 1.12 X | |||
Book Value Per Share | 5.59 X | |||
Cash Flow From Operations | 490 M | |||
Earnings Per Share | 0.41 X | |||
Number Of Employees | 15 K | |||
Beta | -0.15 | |||
Market Capitalization | 8.37 B | |||
Total Asset | 7.46 B | |||
Retained Earnings | 201.98 M | |||
Working Capital | 59 M | |||
Current Asset | 1.09 B | |||
Current Liabilities | 1.03 B | |||
Z Score | 0.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in IMS Stock
If you are still planning to invest in IMS Health Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IMS Health's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
CEOs Directory Screen CEOs from public companies around the world |